New research published in BMC Public Health reports that place of residence can affect lung cancer risk, in addition to well known individual risk factors like smoking. The short public summary presents the main finding but does not list every local pattern the authors examined.
The paper names Veronica Bernacchi as a coauthor; she is an assistant professor at the Michigan State University College of Nursing. Other contributors include experts from the MSU College of Human Medicine public health department, staff at Henry Ford Health, and researchers at the Pennsylvania State University College of Medicine.
The team analysed publicly available county-level measures from the 2022 County Health Rankings and Roadmaps website. The summary notes the use of these public data but does not give full methodological detail. It is also not yet clear what policy or public health actions the authors recommend. Readers who want full data and analysis should consult the paper in BMC Public Health or contact the authors.
Difficult words
- place of residence — town or area where a person lives
- coauthor — a person who wrote a paper with others
- publicly available — open for anyone to use or read
- county-level measure — a statistic for a specific county areacounty-level measures
- methodological — related to the methods used in research
- consult — look at or ask for official information
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How might place of residence affect a person's lung cancer risk? Give one or two examples.
- Do you think publicly available county-level data is useful for local health decisions? Why or why not?
- If you wanted more detail from this study, what steps would you take?
Related articles
Older adults more exposed to low-credibility online health information
Researchers at the University of Utah tracked web activity of more than 1,000 US adults for four weeks. They found low-credibility health sites were rare overall but visits were concentrated among older adults, especially those who lean right politically.
Lower chemotherapy dose helps people 80+ with lymphoma
A study found that people aged 80 and older with a common lymphoma often do better with a lower chemotherapy dose. Researchers used data from community cancer clinics and say the smaller dose kept effectiveness while reducing side effects.